伊马替尼诱发的史蒂文斯-约翰逊综合征。
Imatinib-induced Stevens-Johnsons syndrome.
作者信息
Jha Praveen, Himanshu D, Jain Nirdesh, Singh Ajay Kumar
机构信息
Department of Internal Medicine, KGMU., Gwalior, Madhya Pradesh, India.
出版信息
BMJ Case Rep. 2013 Jan 23;2013:bcr2012007926. doi: 10.1136/bcr-2012-007926.
Abstract
Imatinib mesylate is a tyrosine kinase inhibitor used widely as the first-line treatment for chronic myeloid leukaemia (CML). The side-effect profile of this drug includes fluid retention, muscle cramps, diarrhoea, myelosuppression and skin rashes. Of these, rashes of the type maculo-papular eruptions and oedema developed most commonly. The cutaneous adverse reactions other than maculo-papular eruptions are rare with imatinib. Severe and life-threatening cutaneous reactions can occur in 5% cases. Here, the author reports a case of newly diagnosed CML that developed Steven-Johnsons syndrome due to imatinib therapy. Patient responded and discharged successfully on withdrawal of the culminating drug.
摘要
甲磺酸伊马替尼是一种酪氨酸激酶抑制剂，被广泛用作慢性粒细胞白血病（CML）的一线治疗药物。该药物的副作用包括液体潴留、肌肉痉挛、腹泻、骨髓抑制和皮疹。其中，最常见的是斑丘疹和水肿型皮疹。伊马替尼引起的除斑丘疹以外的皮肤不良反应很少见。5%的病例可能会发生严重的、危及生命的皮肤反应。在此，作者报告一例新诊断的CML患者，因伊马替尼治疗发生了史蒂文斯-约翰逊综合征。患者在停用最终导致不良反应的药物后病情好转并成功出院。
相似文献
1
Imatinib-induced Stevens-Johnsons syndrome.伊马替尼诱发的史蒂文斯-约翰逊综合征。
BMJ Case Rep. 2013 Jan 23;2013:bcr2012007926. doi: 10.1136/bcr-2012-007926.
2
Stevens-Johnson syndrome after treatment with STI571: a case report.接受STI571治疗后发生史蒂文斯-约翰逊综合征：一例报告
Br J Haematol. 2002 Jun;117(3):620-2. doi: 10.1046/j.1365-2141.2002.03499.x.
3
Late onset imatinib-induced Stevens-Johnson syndrome.晚期伊马替尼诱发的史蒂文斯-约翰逊综合征。
J Oncol Pharm Pract. 2014 Dec;20(6):476-8. doi: 10.1177/1078155213518226. Epub 2014 Jan 7.
4
Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):288-9. doi: 10.4103/0378-6323.16628.
5
Spotlight on imatinib mesylate in chronic myeloid leukemia.聚焦甲磺酸伊马替尼治疗慢性髓性白血病
BioDrugs. 2004;18(3):207-10. doi: 10.2165/00063030-200418030-00009.
6
Imatinib mesylate in the treatment of chronic myeloid leukaemia.甲磺酸伊马替尼治疗慢性髓性白血病。
Expert Opin Pharmacother. 2003 Jun;4(6):963-71. doi: 10.1517/14656566.4.6.963.
7
Sti571-induced Stevens-Johnson Syndrome.
Br J Haematol. 2002 Oct;119(1):274-5. doi: 10.1046/j.1365-2141.2002.37133.x.
8
Management of the new patient with CML in chronic phase.慢性期新慢性髓性白血病患者的管理。
Curr Hematol Malig Rep. 2013 Mar;8(1):37-42. doi: 10.1007/s11899-012-0151-0.
9
[A rare complication of imatinib mesylate therapy: drug-induced pneumonitis].[甲磺酸伊马替尼治疗的一种罕见并发症：药物性肺炎]
Ter Arkh. 2010;82(2):59-61.
10
A patient of chronic myelogenous leukemia developing painful rash on feet.一名慢性粒细胞白血病患者足部出现疼痛性皮疹。
J Postgrad Med. 2012 Oct-Dec;58(4):331-4. doi: 10.4103/0022-3859.105489.
引用本文的文献
1
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.免疫检查点抑制剂和肿瘤靶向治疗诱导的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的新见解
J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.
2
Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs-An Overview.抗肿瘤药物迟发型超敏反应的评估——综述
Cancers (Basel). 2023 Feb 14;15(4):1208. doi: 10.3390/cancers15041208.
3
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).与酪氨酸激酶抑制剂相关的潜在危及生命的严重皮肤不良反应（综述）。
Oncol Rep. 2021 Mar;45(3):891-898. doi: 10.3892/or.2020.7911. Epub 2020 Dec 24.
4
Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).严重皮肤不良反应表皮坏死松解症（EN）的临床和发病方面。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1957-1971. doi: 10.1111/jdv.16339. Epub 2020 May 15.
5
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.靶向抗癌疗法和免疫疗法引起的严重皮肤不良反应。
Cancer Manag Res. 2018 May 17;10:1259-1273. doi: 10.2147/CMAR.S163391. eCollection 2018.
6
Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症；药物诱发病因报告及可能治疗方式的广泛综述
Open Access Maced J Med Sci. 2018 Mar 28;6(4):730-738. doi: 10.3889/oamjms.2018.148. eCollection 2018 Apr 15.
7
Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!史蒂文斯-约翰逊综合征-中毒性表皮坏死松解症的管理：超越指南！
Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17.
8
Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.抗癌药物引起的严重皮肤不良反应：抗癌靶向治疗或免疫治疗相关风险的最新综述。
J Immunol Res. 2018 Jan 17;2018:5376476. doi: 10.1155/2018/5376476. eCollection 2018.
9
Life-threatening dermatologic adverse events in oncology.肿瘤学中危及生命的皮肤不良反应。
Anticancer Drugs. 2014 Feb;25(2):225-34. doi: 10.1097/CAD.0000000000000032.
本文引用的文献
1
Oral lichenoid eruption secondary to imatinib (Glivec).
J Dermatolog Treat. 2004 Jul;15(4):253-5. doi: 10.1080/09546630410015556.
2
Imatinib mesylate causes hypopigmentation in the skin.甲磺酸伊马替尼可导致皮肤色素减退。
Cancer. 2003 Dec 1;98(11):2483-7. doi: 10.1002/cncr.11812.
3
[Imatinib-induced purpuric vasculitis].
Ann Dermatol Venereol. 2003 Aug-Sep;130(8-9 Pt 1):765-7.
4
Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign.
Dermatology. 2003;207(3):329-30. doi: 10.1159/000073102.
5
Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2003 May;82(5):303-4. doi: 10.1007/s00277-003-0643-z. Epub 2003 Apr 18.
6
A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec).
Br J Haematol. 2003 Mar;120(5):911-3. doi: 10.1046/j.1365-2141.2003.04151_4.x.
7
Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia.一例费城染色体阳性急性淋巴细胞白血病患者对伊马替尼发生严重皮肤反应。
Blood. 2003 Mar 15;101(6):2446. doi: 10.1182/blood-2002-12-3696.
8
Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients.伊马替尼（STI571）治疗费城染色体阳性白血病的皮肤不良反应：54例患者的前瞻性研究
J Am Acad Dermatol. 2003 Feb;48(2):201-6. doi: 10.1067/mjd.2003.44.
9
Managing cutaneous reactions to imatinib therapy.
Blood. 2002 Nov 1;100(9):3434-5. doi: 10.1182/blood-2002-08-2431.
10
Sti571-induced Stevens-Johnson Syndrome.
Br J Haematol. 2002 Oct;119(1):274-5. doi: 10.1046/j.1365-2141.2002.37133.x.
Zotero 插件